Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell & Gene Therapy Asia 2019

Abstract



Recent Advancements in Research Based on 3D Bioprinting Technology – From Single Cells to Miniature Organs

Haruka Yoshie, Application Specialist, CELLINK

Additive manufacturing has made a resounding impact on many traditional manufacturing industries, allowing for custom and free-form manufacturing of parts. This has overlapped to the biomedical space for implants and prosthetics with large-scale metal and plastic printers gaining traction as custom solutions to patient-specific implants.

Despite growth in traditional sectors and the emerging market for 3D bioprinting, the use of 3D bioprinting as a custom solution for bio-applications in the pharmaceutical and bio-manufacturing industries has not yet been achieved. Many problems stem from low throughput of manufactured materials, lack of education in additive manufacturing, and the elusiveness of single-micron manufacturing.

While technology for additive fabrications has been used extensively in the research space, this talk will focus on the future role of additive manufacturing within biological industries, and the technology being developed that will drive it.


Add to Calendar ▼2019-11-11 00:00:002019-11-12 00:00:00Europe/LondonCell and Gene Therapy Asia 2019Cell and Gene Therapy Asia 2019 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com